fashion -WSS

fashion

author：Wikipedia 2025-09-06 02:15:19 - browse：4939

STAT's Casey Ross (left) and Kimberly Powell, NVIDIA's vice president for healthcare at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?

The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.

Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that cite AI, as well as an uptick in early-stage readouts from clinical trials, as evidence of progress. Some of the recent readouts, Powell said, show that what’s going into Phase 1 clinical trials is more successful.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Vertigo drug brings hope for rare neuron disorder, Niemann

WSS

New Ultima Genomics DNA sequencer can read genome for $100

Covid misinformation case heads to Supreme Court

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Congressmen charge Covid hearing ‘could have been an email’

New Ultima Genomics DNA sequencer can read genome for $100

A $475,000 price tag for a new cancer drug: crazy or meh?

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

In Memoriam: Notable people who died in 2023

Congressmen charge Covid hearing ‘could have been an email’

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Juul spent big to court Black leaders to promote its e

How to save PrEP access — and even expand it

Congressmen charge Covid hearing ‘could have been an email’

Continuity nursing helped my family in our darkest PICU moments

What we need to know about Arena Bioworks

focus

Apple Vision Pro: A first look at health apps on the new VR headset

New Ultima Genomics DNA sequencer can read genome for $100

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Juul spent big to court Black leaders to promote its e

Time to name cancers by genetics, not organ of origin, expert says

leisure time

focus

leisure time

hotspot